Media Release

advertisement
A media alert for the journal Chemistry & Biology.
EMBARGOED RELEASE
Media Contact: Joseph Caputo | Press Office | Cell Press
617-397-2802 | jcaputo@cell.com | press@cell.com
STRICTLY UNDER EMBARGO UNTIL 12:00PM NOON ET (US) ON THURSDAY, MARCH 5, 2015
Molecule Found in Tree Leaves Helps Female Mice Combat Weight Gain; Males Unaffected
A small molecule that binds to a receptor found on muscle cells speeds up energy metabolism—but
only in female mice. In an article published online on March 5 in Chemistry & Biology, researchers
show that female mice treated with a molecule found in tree leaves could indulge in high-fat foods
without gaining weight or accumulating fat. Males did not enjoy similar benefits, highlighting the need
to study both sexes while developing drugs for obesity and other conditions.
“An equivalent diet pill in humans would allow women to eat or drink whatever they wanted,” says
senior author Dr. Keqiang Ye, of the Emory University School of Medicine in Atlanta. “The pill would
burn calories without affecting appetite.”
Research has shown that a hormone called brain-derived neurotrophic factor (BDNF), which is
secreted after physical exercise, controls body weight gain by eliciting signals to suppress food intake
and enhance energy expenditure. Manipulation of this signaling represents a promising strategy for
combating obesity; however, BDNF degrades quickly in the body.
While developing a drug for neurological diseases, Dr. Ye and his colleagues discovered that a small
natural product called 7,8-dihydroxyflavone (7,8-DHF) that is found in Godmania aesculifolia and
primula tree leaves from Central and South America mimics the physiological functions of BDNF. The
molecule seems to work by interfering with enzymes that acts as the body’s fuel gauge.
When mice were fed 7,8-DHF along with a high-fat diet, females maintained their appetite but kept a
healthy weight and metabolic profile without demonstrable side effects; males, on the other hand, still
developed obesity and diabetes. The mechanisms behind this sex difference are unknown, but sexspecific hormones might play a role. For example, estrogen has been proposed to enhance the
effects of BDNF signaling, and 7,8-DHF was reported to alter estrogen metabolism.
Dr. Ye’s team has designed a biological agent that helps 7,8-DHF be absorbed by the body. It is now
heading for phase I human clinical trials treating various BDNF-implicated neurological diseases—
including Alzheimer’s—as well as obesity and diabetes.
“This drug has been extensively tested in a variety of neurological diseases in both male and female
animal models and exhibits very promising therapeutic efficacy, suggesting that this drug is
efficacious for both sexes in the central nervous system,” Ye said. “Clearly, further investigation is
necessary to explore why it selectively burns the fat for the female mice.”
###
This work is supported by grants from National Institute of Health and the Oklahoma Center for the
Advancement of Science & Technology.
Chemistry & Biology, Chan et al.: “Activation of Muscular TrkB by its Small Molecular Agonist 7,8Dihydroxyflavone Sex-dependently Regulates Energy Metabolism in Diet-induced Obese Mice”
In online coverage, please mention the journal Chemistry & Biology and link to the paper
at http://www.cell.com/chemistry-biology/abstract/S1074-5521(15)00041-1
To access the paper proof PDF, please visit this
dropbox: https://www.dropbox.com/sh/m2devgsbpiyo8j2/AADUgeV1Lr2pIYfyCR_N2zWpa?dl=0 or email Joseph Caputo at jcaputo@cell.com.
Author Contact:
Keqiang Ye
Professor, Pathology & Laboratory Medicine
Emory University School of Medicine
kye@emory.edu
404-712-2814
Media Contact:
Quinn Eastman
Emory University School of Medicine
qeastma@emory.edu
404-727-7829
Download